Skip to main content
. Author manuscript; available in PMC: 2017 Jan 3.
Published in final edited form as: Clin Cancer Res. 2010 Mar 9;16(6):1726–1736. doi: 10.1158/1078-0432.CCR-09-1961

Figure 4.

Figure 4

(Top panel) Definition of PD “response” for an individual patient. Multipliers of the baseline SD are derived from asymptotic normal distribution theory. Significance levels are 1-sided. (Bottom panel) Definition of a promising observed response rate for a dose level with a 2-stage design. The target (true) PD response rate, across patients, is 60%. Power and false positive rate are derived from the binomial distribution. Adapted with permission from Murgo, et al (41)